Abstract:The interaction of remifentanil with glutamate systems has an important role in remifentanil-induced thermal and mechanical hyperalgesia. A previous study by our group suggested that the trafficking and function of glutamate receptor 1 (GluR1) subunits contributes to remifentanil-induced hyperalgesia by regulating the phosphorylation of GluR1 in dorsal horn neurons. The present study demonstrated that δ opioid receptor (DOR) inhibition prevented thermal and mechanical hyperalgesia, which was induced by remifentanil infusion via attenuating GluR1 subunit trafficking and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) function in dorsal horn neurons. Sprague Dawley rats received a plantar incision and remifentanil infusion to induce a model of postoperative hyperalgesia. Thermal and mechanical pain was tested at 8 different time-points. Expression of AMPAR subunits GluR1 and DOR, as well as the phosphorylation status of GluR1 were evaluated by western blot analysis. Furthermore, the function of AMPAR in the spinal dorsal horn was measured by whole-cell patch-clamp recording. Remifentanil-induced thermal and mechanical hyperalgesia appeared after the 60-min infusions, reaching a peak level on day 2 and persisting for 5 days. Remifentanil infusion led to upregulation of membrane expression of the AMPAR subunit GluR1 and DOR (P=0.003 and 0.001, respectively) no change in total GluR1 and DOR expression levels (P=0.244 and 0.531, respectively). Selective DOR inhibitor naltrindole caused a reduction of remifentanil-induced hyperalgesia, which was accompanied by downregulation of membrane levels of GluR1 in the spinal cord (P=0.0013). In addition, DOR inhibition led to downregulation of GluR1 phosphorylated at Ser845. Furthermore, the AMPAR-mediated miniature excitatory post-synaptic current was increased in frequency and in amplitude in dorsal horn neurons (P=0.002 and 0.0011, respectively), which was decreased by incubation with naltrindole. Combined behavioral, western blot and electrophysiological evidence indicated that remifentanil-induced hyperalgesia was mediated by DOR activation, followed by phosphorylation-dependent GluR1 trafficking and AMPAR function enhancement in the spinal cord. DOR appears to be required for remifentanil and incision-induced hyperalgesia development and to be a potential biochemical target for treating opioid-induced postoperative hyperalgesia.

X-ray CT detection and photo ablation of metastatic positive lymph node with HER-2 targeting W18O49 platform

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

Intrathecal Injection of KN93 Attenuates Paradoxical Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Spinal CaMKII Phosphorylation in Rats

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

Tyrosine Phosphorylation of the N-Methyl-D-Aspartate Receptor 2B Subunit in Spinal Cord Contributes to Remifentanil-Induced Postoperative Hyperalgesia: the Preventive Effect of Ketamine

Antinociception and Prevention of Hyperalgesia by Intrathecal Administration of Ro 25-6981, a Highly Selective Antagonist of the 2B Subunit of N-methyl-d-aspartate Receptor

Effects of CaMK Ⅱ Inhibitor KN93 on Remifentanil-Induced Hyperalgesia

[Changes of Mu-opioid receptor and neuron-restrictive silencer factor in periaquductal gray in mouse models of remifentanil-induced postoperative hyperalgesia]

Activation of Spinal Alpha-7 Nicotinic Acetylcholine Receptor Attenuates Remifentanil-Induced Postoperative Hyperalgesia.

Activation of Spinal Alpha-7 Nicotinic Acetylcholine Receptor Shortens the Duration of Remifentanil-Induced Postoperative Hyperalgesia by Upregulating KCC2 in the Spinal Dorsal Horn in Rats

Neuron-restrictive silencer factor in periaqueductal gray contributes to remifentanil-induced postoperative hyperalgesia via repression of the mu-opioid receptor

Intrathecal injection of JWH015 attenuates remifentanil-induced postoperative hyperalgesia by inhibiting activation of spinal glia in a rat model.

The Effect of Cannabinoid Receptor 2 Agonist JWH015 on the Hyperalgesia Induced by Remifentanil

The Influence of Ketamine on KCC2 in Spinal Cord of Rat in Remifentanil-Induced Hyperalgesia

Intraoperative Electroacupuncture Relieves Remifentanil-Induced Postoperative Hyperalgesia Via Inhibiting Spinal Glial Activation in Rats

Δ-opioid receptor inhibition prevents remifentanil-induced post-operative hyperalgesia via regulating GluR1 trafficking and AMPA receptor function

Effects of Different Dose of KN93 on Remifentanil-Induced Hyperalgesia

Effect of Intrathecal Injection JWH015 on the Remifentani-Induced Hyperalgesia in Rats

Intrathecal Administration of Roscovitine Prevents Remifentanil-Induced Postoperative Hyperalgesia and Decreases the Phosphorylation of N-methyl-D-aspartate Receptor and Metabotropic Glutamate Receptor 5 in Spinal Cord.

Effects of Ketamine Pretreatment on Preventing Remifentanil-Induced Hyperalgesia

Blocking SphK/S1P/S1PR1 axis signaling pathway alleviates remifentanil-induced hyperalgesia in rats